The World Health Organization (WHO) has announced new guidelines for human immunodeficiency virus (HIV) prevention and ...

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

This decentralized approach aims to make treatment much easier to access, especially for those facing travel difficulties, ...

The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice ...

HIV antivirals may be the key to stopping HTLV-1, a deadly virus with no cure. In a decade-long study, researchers successfully suppressed the virus in mice and discovered a way to kill infected cells ...

WHO releases new guidelines recommending injectable lenacapavir for HIV prevention: Geneva Wednesday, July 16, 2025, 10:00 Hrs [IST] The World Health Organization (WHO) released n ...

Alarice Marsh, M.P.H., a deputy director in the National Department of Health of South Africa and program lead of HIV testing ...

Innovation, inclusion, and urgency  define Kigali HIV conference ANALYSIS | RONALD MUSOKE | When the 13th International AIDS ...

New guidance recommends routine anal cancer screening for people with HIV following trial data showing reduced risk from ...

Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

Rwanda is among the countries interested in Lenacapavir, a newly approved, long-acting preventive injection, though its cost is seemingly out of reach for many developing countries.